New implant aims to silence snoring and save lives

NCT ID NCT07331285

Recruiting now Disease control Sponsor: Nyxoah Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a device called the Genio® System for people with moderate to severe obstructive sleep apnea who cannot use CPAP machines. The device is implanted and stimulates the tongue to keep the airway open during sleep. Researchers will track how well it reduces breathing pauses and oxygen drops over five years in 229 adults.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Genio® System 2.1 (implantable device that stimulates the tongue to keep the airway open during sleep)
What this could lead to: If successful, this could provide a long-term treatment option for people with obstructive sleep apnea who cannot tolerate standard CPAP therapy.
What could go wrong: This is a single-arm study (no comparison group), so results may be less definitive. Risks include device-related side effects or the therapy not working for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBSTRUCTIVE SLEEP APNEA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

obstructive sleep apnea syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBSTRUCTIVE SLEEP APNEA

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

Nyxoah, Inc
NOT_YET_RECRUITING

Summit, New Jersey, 07901, United States

Contact Email: •••••@•••••

Contact Email: •••••@•••••
PharmaDev Clinical Research Institute, LLC
RECRUITING

Miami, Florida, 33176, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.